Last reviewed · How we verify
Acetylglucosamine (N-ACETYLGLUCOSAMINE)
Acetylglucosamine (generic name: N-ACETYLGLUCOSAMINE) is a N-Acetylglucosamine drug. It is currently FDA-approved.
Acetylglucosamine works by interacting with glycosaminoglycans in the body, influencing various biological processes.
Acetylglucosamine, also known as N-Acetylglucosamine, is a small molecule drug in the N-Acetylglucosamine class. It is a naturally occurring compound found in the body, involved in various biological processes. However, there is limited information available on its commercial status and approved indications. Further research is needed to determine its efficacy and safety profile. As a result, it is not possible to provide a comprehensive summary of its clinical use.
At a glance
| Generic name | N-ACETYLGLUCOSAMINE |
|---|---|
| Drug class | N-Acetylglucosamine |
| Target | Killer cell lectin-like receptor subfamily B member 1A |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Mechanism of action
Think of glycosaminoglycans like a network of roads in the body. Acetylglucosamine helps to maintain and repair this network, which is important for healthy joints, skin, and other tissues. By doing so, it may help to alleviate symptoms of certain conditions.
Approved indications
Common side effects
Key clinical trials
- Oral N-acetylglucosamine in Crohn's Disease (PHASE2)
- A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth (NA)
- Study on Structum® in Adult Patients With Osteoarthritis (TRUST)
- Effect of Shockwaves on Fallopian Tubes Adhesion (NA)
- Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections (NA)
- Hyaluronic Acid Gel in Ridge Preservation (PHASE4)
- Is Hyaluronic Acid Gel Effective on Oral Mucositis in Children Who Receiving Chemotherapy (PHASE4)
- N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetylglucosamine CI brief — competitive landscape report
- Acetylglucosamine updates RSS · CI watch RSS
Frequently asked questions about Acetylglucosamine
What is Acetylglucosamine?
How does Acetylglucosamine work?
What is the generic name of Acetylglucosamine?
What drug class is Acetylglucosamine in?
What development phase is Acetylglucosamine in?
What does Acetylglucosamine target?
Related
- Drug class: All N-Acetylglucosamine drugs
- Target: All drugs targeting Killer cell lectin-like receptor subfamily B member 1A
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing